Stay updated on Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T13:48:45.000Z thumbnail image
  4. Check
    16 days ago
    No Change Detected
  5. Check
    23 days ago
    Change Detected
    Summary
    The page has been updated to include the term 'Hepatocellular Carcinoma' and a new registry identifier, while significant details about the study's design, participant criteria, and treatment protocols have been removed.
    Difference
    13%
    Check dated 2025-04-16T01:44:47.000Z thumbnail image
  6. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 20, 2025.
    Difference
    0.2%
    Check dated 2025-04-08T20:27:46.000Z thumbnail image
  7. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T15:37:22.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The webpage has updated its last update dates to February 2025, indicating a shift in the timeline for content relevance.
    Difference
    1%
    Check dated 2025-03-03T22:16:05.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.7%
    Check dated 2025-02-10T09:32:58.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.